Ocugen (OCGN) Net Cash Flow (2014 - 2026)
Ocugen (OCGN) posted Net Cash Flow of $13.2 million for Q1 2026, up 194.21% on a QoQ basis from -$14.0 million in Q4 2025, and up 163.68% year-over-year from $5.0 million in Q1 2025.
Ocugen (OCGN) Net Cash Flow (2014 - 2026) Analysis & Trends
Ocugen's Net Cash Flow history runs 13 years deep, the most recent figure standing at $13.2 million for Q1 2026.
- Quarterly Net Cash Flow rose 163.68% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.1 million (down 151.7% YoY) and the FY2025 annual result came in at -$39.9 million, down 306.65% from the prior year.
- Net Cash Flow was $13.2 million for Q1 2026 at Ocugen, up from -$14.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $34.8 million in Q1 2022 and bottomed at -$24.0 million in Q4 2022.
- A 5-year average of -$3.7 million and a median of -$10.8 million in 2025 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 241.31% in 2024, while the deepest fall reached 547.18% in 2024.
- Ocugen's Net Cash Flow stood at -$24.0 million in 2022, then surged by 41.72% to -$14.0 million in 2023, then soared by 241.31% to $19.8 million in 2024, then slumped by 170.69% to -$14.0 million in 2025, then surged by 194.21% to $13.2 million in 2026.
- Business Quant data shows OCGN's Net Cash Flow at $13.2 million in Q1 2026, -$14.0 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.18 Mn |
| Mar 31, 2026 | 13.18 Mn |
| Dec 31, 2025 | -13.99 Mn |
| Dec 31, 2025 | -13.99 Mn |
| Sep 30, 2025 | 5.51 Mn |
| Sep 30, 2025 | 5.51 Mn |
| Jun 30, 2025 | -10.76 Mn |
| Jun 30, 2025 | -10.76 Mn |
| Mar 31, 2025 | -20.70 Mn |
| Mar 31, 2025 | -20.70 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Sep 30, 2024 | 23.01 Mn |
| Sep 30, 2024 | 23.01 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -13.09 Mn |
| Mar 31, 2024 | -13.09 Mn |
| Dec 31, 2023 | -14.01 Mn |
| Dec 31, 2023 | -14.01 Mn |